At ASCO, Dr. Nina Balanchivadze of Sarah Cannon Research Institute at Virginia Oncology Associates and Dr. Kyle Lavin of the UNC School of Medicine shared insights on integrating behavioral health into oncology care. In this interview with BioPharma ... Read more
While we will need to wait for the National Commission into the Regulation of AI in Healthcare's recommendations later this summer, and then the MHRA’s response, to understand the detail of any new requirements, a clear direction of tra... Read more
BriaCell is advancing a new generation of cancer immunotherapies designed to improve outcomes for patients with metastatic breast cancer and other solid tumours. In this interview with BioPharma Boardroom, Dr. William Williams, CEO of BriaCell, discu... Read more
As the biologics landscape grows increasingly complex, CDMOs are under pressure to deliver more than additional manufacturing capacity. Emerging biotechs and established innovators alike are seeking partners capable of integrating development, anal... Read more
Senior secured term loan of up to CHF 250 million with a 5‑year maturity at a fixed 7% interest rate First tranche will fully refinance the existing New Money Facility, maturing in May 2027 Eliminates near‑term debt maturities and strengthens b... Read more
Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable sales Income from operations increased to EUR 241 million Adjusted EBITA margin increased 40 basis points t... Read more
Helvoet is an advanced medical CDMO specializing in highly automated micro-molding and precision injection molding for microfluidics, diagnostics, and drug delivery applications Acquisition establishes a global medical CMO platform by expa... Read more
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi — Drug Substance Facility 2 (MFG2) and Drug Product Facility 1 (DP1)... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
